10-Q: Scepter Holdings Grapples with Mounting Liabilities and Going Concern Doubts Amidst Strategic Acquisition Push
Sentiment:
Quarterly Report
Scepter Holdings, Inc. reported a significant increase in liabilities and a worsening working capital deficit for the quarter ended December 31, 2024, despite a reduced net loss, as it navigates a critical acquisition and ongoing going concern issues.
Delay expectedThe closing of the Ballengee Group LLC merger agreement is conditioned upon a reverse split and an increase in authorized shares of the company, and is expected to close 'as soon as those conditions are met,' implying it has not yet closed and is awaiting these actions.The company explicitly states, 'There are no guarantees that we can meet all of the requirements for closing of the Merger Agreement,' and 'The Company cannot provide any guarantees or assurances that the closing of the Merger Agreement will occur.'The company also mentions 'Our late disclosure filings caused by a lack of funding due to the impact of the pandemic' as a risk factor, indicating past delays in regulatory compliance.
Capital raiseThe company intends to finance operating costs through continued financial support from its stockholders, the issuance of debt securities, and private placements of common stock.The company has settled some liabilities with share-based compensation and convertible debt in the past and may continue to do so.The pending acquisition of Ballengee Group LLC involves the issuance of $30 million of Scepter common stock and a $17 million 5-year promissory note to the sellers.The company issued a $50,000 convertible note agreement on October 15, 2024, bearing 12% interest.The company issued two $100,000 related party convertible note agreements on September 24, 2024, and October 30, 2024, each bearing 12% interest.The company issued new notes payable of $353,431 for the nine months ended December 31, 2024.The company plans to convert a related party note payable to Market Group International (totaling $278,583 including accrued interest) into common stock during the quarter ending March 31, 2025.
Worse than expectedRevenues for the nine months ended December 31, 2024, decreased by 61% compared to the prior year, indicating a significant decline in core business activity.Total liabilities more than doubled, and the working capital deficit worsened significantly, highlighting deteriorating financial health.The company continues to operate under substantial doubt about its ability to continue as a going concern.Disclosure controls and procedures were deemed ineffective, raising concerns about financial reporting reliability.
Summary
- Net loss for the nine months ended December 31, 2024, decreased to $715,945 from $1,349,571 in the prior year, primarily due to reduced professional fees and general and administrative expenses.
- Revenues for the nine months ended December 31, 2024, significantly declined by 61% to $4,222 from $10,966 in the same period last year, attributed to decreased marketing efforts.
- Cash balance increased to $25,662 as of December 31, 2024, from $702 as of March 31, 2024.
- Total liabilities surged to $1,104,922 as of December 31, 2024, from $493,366 as of March 31, 2024.
- The working capital deficit worsened to $1,071,372 as of December 31, 2024, from $483,760 as of March 31, 2024.
- The company continues to face substantial doubt about its ability to continue as a going concern, having incurred accumulated losses of $9,268,195 since inception.
- A merger agreement with Ballengee Group LLC (BG), a sports management agency, was signed on March 25, 2024, involving $30 million in Scepter common stock and a $17 million promissory note, contingent on a reverse stock split and increased authorized shares.
- The company's AI-powered Adapti platform, developed for influencer marketing, has cost approximately $500,000 in fiscal years 2023 and 2024 and has not yet generated revenue.
Sentiment
Score: 2
Explanation: The company faces severe financial distress, including a significant working capital deficit, accumulated losses, and declining revenue from its existing business. While a strategic acquisition is pending, its closing is uncertain and the company explicitly states substantial doubt about its ability to continue as a going concern. Ineffective internal controls further compound the negative outlook.
Positives
- Net loss for the nine months ended December 31, 2024, decreased to $715,945 from $1,349,571 in the prior year, primarily due to reduced operating expenses.
- Cash balance increased to $25,662 as of December 31, 2024, from $702 as of March 31, 2024.
- Net cash used in operating activities decreased to $225,040 for the nine months ended December 31, 2024, from $318,934 in the prior year.
- The company is pursuing a strategic acquisition of Ballengee Group LLC, a sports management agency, which is expected to generate sufficient cash flow from operations.
- Development of the Adapti AI platform for influencer marketing is ongoing, with beta testing completed in 2023 and some live transactions in 2024.
Negatives
- Revenues for the nine months ended December 31, 2024, significantly decreased by 61% to $4,222 from $10,966 in the prior year, primarily due to decreased marketing efforts.
- Total liabilities more than doubled to $1,104,922 as of December 31, 2024, from $493,366 as of March 31, 2024.
- The working capital deficit worsened to $1,071,372 as of December 31, 2024, from $483,760 as of March 31, 2024.
- The company has incurred accumulated losses totaling $9,268,195 since inception and has not yet generated significant revenue.
- Interest expense significantly increased to $38,002 for the nine months ended December 31, 2024, from $0 in the prior year, due to new interest-bearing notes.
- The Adapti platform has not generated any revenues despite approximately $500,000 in development costs incurred in fiscal years 2023 and 2024.
- The company's disclosure controls and procedures were deemed not effective as of December 31, 2024.
- The company is not in compliance with its note with Market Group International as of December 31, 2024.
Risks
- Current lack of working capital and inability to raise additional financing.
- Reliance on management estimates for accounting policies, which are inherently uncertain.
- Potential deterioration in general or regional economic conditions.
- Risk of adverse state or federal legislation, regulation, or findings by regulators.
- Inability to efficiently manage operations or achieve future sales levels.
- Unavailability of funds for capital expenditures.
- Lack of cash and late disclosure filings attributed to the impact of the pandemic.
- Limited number of personnel may lead to limited controls and procedures.
- The Chief Financial Officer also serves as CFO for another company, potentially leading to time conflicts.
- Lack of an independent director on the Board of Directors.
- The Chief Executive Officer, as a significant shareholder, may control the company.
- Dependence on a small customer base for current revenue.
- No guarantees that the conditions for the closing of the Ballengee Group LLC merger agreement will be met.
Future Outlook
The company expects to close the acquisition of Ballengee Group LLC, which is anticipated to generate sufficient cash flow from operations. It plans to finance future operating costs through continued financial support from stockholders, issuance of debt securities, and private placements of common stock. The company also intends to file a registration statement for the shares issued in the Ballengee acquisition within 90 days of closing. The Adapti platform is expected to become part of the strategy with the Ballengee acquisition to assist clients with social media opportunities.
Management Comments
- The company's ability to continue as a going concern is dependent upon its ability to generate future profitable operations and to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they become due.
- While the company strongly believes that its capital resources will be sufficient in the near term, there is no assurance that the company's activities will generate sufficient revenues to sustain its operations without additional capital or, if additional capital is needed that such funds, if available, will be obtainable in terms of satisfactory to the company.
- The company believes its existing cash and expected cash flows from operations will not be sufficient to meet our working capital, capital expenditures, and expected cash requirements from known contractual obligations for the next twelve months and beyond. It will need to raise additional capital to continue operations.
- Our disclosure controls and procedures, as of December 31, 2024, were not effective such that the information required to be disclosed by us in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding disclosure.
Industry Context
Scepter Holdings operates in a challenging intersection of direct-to-consumer skincare (Dermacia), AI-driven marketing technology (Adapti), and is expanding into sports management through the pending Ballengee Group acquisition. The company's strategy to integrate its AI platform with a sports management agency suggests an attempt to leverage technology for client acquisition and engagement in a specialized service industry. The decline in Dermacia revenue indicates struggles in its existing D2C business, while the AI platform is still in development without revenue generation. The move into sports management represents a significant pivot or diversification, aiming for a more stable revenue stream, contrasting with the high-risk, high-reward nature of tech development and D2C e-commerce.
Comparison to Industry Standards
- NA The document does not provide specific comparable companies, projects, or results to assess performance against global benchmarks.
- The company's current financial state, characterized by minimal revenue, significant accumulated deficits, and going concern issues, suggests it is far from meeting typical profitability or liquidity standards for established companies in any of its stated industries (skincare, AI tech, sports management).
- Its reliance on debt and equity financing for operations is common for early-stage or distressed companies, but the lack of revenue from its core tech product (Adapti) and declining revenue from its existing product line (Dermacia) indicates underperformance relative to growth expectations for a company developing new technology or expanding into new sectors.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Robert Van Boreum | Adam Nicosia | NA | Robert Van Boreum is referred to as 'ex-Chief Executive Officer' and Adam Nicosia as 'current Chief Executive Officer' in the filing. |
| Chief Financial Officer | NA | Samuel Weiss | NA | Samuel Weiss is identified as the interim Chief Financial Officer and certifies the report in this capacity. |
| Chief Executive Officer (for certification purposes) | NA | Samuel Weiss | NA | Samuel Weiss certifies the report as Chief Executive Officer, despite Adam Nicosia signing the main filing as CEO, indicating a potential dual role or specific certification responsibility for compliance. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Controls Effectiveness | Disclosure controls and procedures were not effective as of December 31, 2024, meaning material information may not be recorded, processed, summarized, and reported timely. | 2024-12-31 | Raises significant concerns about the reliability and accuracy of financial reporting and the company's ability to make timely disclosure decisions. |
| Internal Control Over Financial Reporting | Identified significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting. | 2024-12-31 | Reasonably likely to adversely affect the company's ability to record, process, summarize, and report financial information reliably. |
| Board Composition | Lack of an independent director on the Board of Directors. | NA | May compromise board oversight and decision-making independence, especially given the CEO's significant shareholding. |
| Management Oversight | The Chief Financial Officer also serves as CFO for another company, potentially leading to limited time and conflicts of interest. | NA | Could impact the effectiveness and dedicated attention to Scepter Holdings' financial management and reporting. |
| Shareholder Control | The Chief Executive Officer is also one of the most significant shareholders, potentially allowing them to control the company. | NA | Raises concerns about potential conflicts of interest and the protection of minority shareholder rights. |
Legal Proceedings
- No pending, threatened, or actual material legal proceedings in which the company is a party.
Related Party Transactions
- Market Group International (owned by ex-CEO Robert Van Boreum): Owed $278,583 (principal and accrued interest) as of December 31, 2024. The company is not in compliance with this note and plans to convert it to common stock by March 31, 2025, at a 20% discount to market price.
- Stuff International (owned by current CEO Adam Nicosia): Owed $202,405 (principal and accrued interest) as of December 31, 2024. This note is not convertible, and its maturity was extended until December 31, 2025.
- EcoScientific Labs (owned by current CEO Adam Nicosia): Received 41,666,667 restricted common shares for Adam Nicosia's management services in Q2 2024, and 62,500,000 restricted common shares for management services in Q4 2023 and Q1 2024.
- Vasil Papov: Received 5,000,000 restricted common shares for professional services in Q4 2024, and 2,500,000 restricted common shares for professional services in Q4 2023 and Q1 2024.
- Johannesen Consulting, Inc. (Thomas Johannesen): Received 5,000,000 restricted common shares for professional services in Q4 2023 and Q3 2023, and 287,430,000 restricted common shares for debt conversion in Q4 2023 and Q3 2023.
- Steven Davis: Received 30,000,000 restricted common shares for professional services in Q4 2024.
Stakeholder Impact
- Shareholders: Significant dilution risk from ongoing issuance of common stock for debt conversion, services, and the large Ballengee acquisition. Existing shareholders face substantial doubt about the company's going concern status and the potential for further value erosion.
- Creditors: Convertible debt and related party notes introduce complexity, with some notes being converted to equity, potentially reducing direct repayment obligations but shifting risk. Non-compliance with one related party note indicates potential default risk.
- Employees: Reduced personnel in 2024 suggests potential workforce adjustments or limited capacity.
- Customers: Declining revenues from Dermacia indicate reduced marketing efforts and potentially less focus on existing product lines, which could impact customer experience or product availability.
- Management: High workload and potential conflicts of interest for the CFO, who also serves another company. The CEO's significant shareholding and control raise governance concerns.
Next Steps
- Close the merger transaction with Ballengee Group LLC, contingent on a reverse stock split and an increase in authorized shares.
- File a registration statement to register the shares of common stock issued to the Ballengee Group sellers within 90 days after the closing date of the merger.
- Raise additional capital through continued financial support from stockholders, issuance of debt securities, and private placements of common stock.
- Convert the Market Group International related party note and accrued interest into common stock during the quarter ending March 31, 2025.
- Integrate the Adapti AI platform into the Ballengee acquisition strategy to assist clients with social media opportunities.
Key Dates
| Date | Description |
|---|---|
| 2007-12-07 | Bylaws of Brazos International Exploration, Inc. (a former name of the company) were adopted. |
| 2018 | Began selling licensed Dermacia products direct to consumers through acquisition of product formulation, inventory, and customer list. |
| 2019 | Began marketing to customers through social media; acquired retail stores in airport terminals and casinos. |
| 2019-10 | Acquired retail stores in airport terminals and casinos. |
| 2020-04-21 | Received an EIDL Advance of $7,000. |
| 2021 | Decided to develop own software system (Adapti) and hired programmers. |
| 2022-07-05 | Santuccio Ricciardi note issued, later converted to 3,282,534 common stock. |
| 2022-07-07 | Wallace Chapiewski note issued, later converted to 3,282,534 common stock. |
| 2022-07-19 | Arnaldo Aleman note issued, later converted to 6,252,446 common stock. |
| 2022-07-26 | William P. Elkins note issued, later converted to 9,847,603 common stock. |
| 2022-08-01 | Carole Alley Family Trust note issued, later converted to 3,126,223 common stock. |
| 2022-08-01 | Donald L. & Hazel J. Christensen Revocable Living Trust note issued, later converted to 3,136,823 common stock. |
| 2022-09-06 | Larry C. Tankson note issued, later converted to 7,288,813 common stock. |
| 2022-09-08 | Bruce A Smith note issued, later converted to 13,810,382 common stock. |
| 2022-09-28 | Paul Kison note issued, later converted to 14,056,996 common stock. |
| 2023 | Began beta testing Adapti. |
| 2023-03-31 | Issued 62,500,000 common shares to EcoScientific Labs for management services. |
| 2023-03-31 | Issued 62,500,000 common shares to Market Group International for management services. |
| 2023-03-31 | Issued 2,500,000 common shares to Vasil Popov for professional services. |
| 2023-03-31 | Issued 5,000,000 common shares to Johannesen Consulting, Inc. for professional services. |
| 2023-04-05 | Issued 14,056,996 common shares to Paul Kison for debt conversion. |
| 2023-06-30 | Issued 62,500,000 common shares to EcoScientific Labs for management services. |
| 2023-06-30 | Issued 62,500,000 common shares to Market Group International for management services. |
| 2023-06-30 | Issued 2,500,000 common shares to Vasil Popov for professional services. |
| 2023-06-30 | Issued 5,000,000 common shares to Johannesen Consulting, Inc. for professional services. |
| 2023-08-29 | Issued 287,430,000 common shares to Johannesen Consulting, Inc. for debt conversion. |
| 2023-09-30 | Issued 62,500,000 common shares to EcoScientific Labs for management services. |
| 2023-09-30 | Issued 62,500,000 common shares to Market Group International for management services. |
| 2023-09-30 | Issued 2,500,000 common shares to Vasil Popov for professional services. |
| 2023-09-30 | Issued 5,000,000 common shares to Johannesen Consulting, Inc. for professional services. |
| 2023-10-27 | Issued 14,861,111 common shares to OC Sparkle for debt conversion. |
| 2023-10-27 | Issued 11,014,706 common shares to OC Sparkle for debt conversion. |
| 2023-10-27 | Issued 14,032,787 common shares to OC Sparkle for debt conversion. |
| 2023-10-27 | Issued 30,571,429 common shares to CZA, Inc. for debt conversion. |
| 2023-12-12 | Market Group International related party note payable of $250,000 entered into. |
| 2023-12-31 | Issued 62,500,000 common shares to EcoScientific Labs for management services. |
| 2023-12-31 | Issued 62,500,000 common shares to Market Group International for management services. |
| 2023-12-31 | Issued 2,500,000 common shares to Vasil Popov for professional services. |
| 2023-12-31 | Issued 5,000,000 common shares to Johannesen Consulting, Inc. for professional services. |
| 2024 | Ran a few live transactions utilizing Adapti in a production environment. |
| 2024-03 | FASB issued Accounting Standards Update 2024-02 and 2024-01. |
| 2024-03-25 | Signed merger agreement with BSG Holdings, LLC and JBAH Holdings, Inc. for Ballengee Group LLC. |
| 2024-03-31 | Issued 62,500,000 common shares to EcoScientific Labs for management services. |
| 2024-03-31 | Issued 2,500,000 common shares to Vasil Popov for professional services. |
| 2024-06-30 | Issued 41,666,667 common shares to EcoScientific Labs for management services. |
| 2024-09-24 | Entered into a $100,000 related party convertible note agreement. |
| 2024-10-15 | Entered into a $50,000 convertible note agreement. |
| 2024-10-30 | Entered into a $100,000 related party convertible note agreement. |
| 2024-11 | FASB issued Accounting Standards Update 2024-04 and 2024-03. |
| 2024-12-15 | Effective date for ASU 2024-02 for public business entities for fiscal years beginning after this date. |
| 2024-12-15 | Effective date for ASU 2024-01 for public business entities for annual periods beginning after this date. |
| 2024-12-31 | End of the quarterly period covered by the report. |
| 2024-12-31 | Issued 30,000,000 common shares to Steven Davis for professional services. |
| 2024-12-31 | Issued 5,000,000 common shares to Vasil Popov for professional services. |
| 2025-02-13 | Date of filing of the Form 10-Q. |
| 2025-02-14 | Number of common shares outstanding was 6,010,887,116. |
| 2025-03-31 | Expected date for conversion of Market Group International note and accrued interest into common stock. |
| 2025-12-15 | Effective date for ASU 2024-02 for all other entities for fiscal years beginning after this date. |
| 2025-12-15 | Effective date for ASU 2024-01 for all other entities for annual periods beginning after this date. |
| 2025-12-31 | Extended maturity date for Stuff International note payable. |
| 2026-12-15 | Effective date for ASU 2024-03 for annual reporting periods beginning after this date. |
| 2027-12-15 | Effective date for ASU 2024-03 for interim reporting periods within annual reporting periods beginning after this date. |
Recommendation
strong sellKeywords
Scepter Holdings, 10-Q, Quarterly Report, Financial Results, Going Concern, Ballengee Group, Acquisition, Sports Management, Adapti, AI Platform, Influencer Marketing, Dermacia, Working Capital Deficit, Net Loss, SEC Filing, Corporate Governance, Related Party Transactions, OTC PINK
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.